Carbamoylcholine homologs: Novel and potent agonists at neuronal nicotinic acetylcholine receptors

Molecular Pharmacology

Volumn 64, Issue 4, 2003, Pages 865-875

  Jensen, Anders A ^a   Mikkelsen, Ivan ^a,b   Frølund, Bente ^a   Bräuner Osborne, Hans ^a   Falch, Erik ^a   Krogsgaard Larsen, Povl ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BioImage AS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE ALPHA2BETA2 RECEPTOR; ACETYLCHOLINE ALPHA3BETA4 RECEPTOR; ACETYLCHOLINE ALPHA4BETA2 RECEPTOR; ACETYLCHOLINE ALPHA4BETA4 RECEPTOR; CARBACHOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; EPIBATIDINE; METHYLCARBACHOL; MUSCARINIC AGENT; N,N DIMETHYLCARBAMOYL N,N DIMETHYLAMINOETHANOL; N,N DIMETHYLCARBAMOYLCHOLINE; NANOPARTICLE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; TERTIARY AMINE; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CHIMERA; CONCENTRATION RESPONSE; DRUG BIOAVAILABILITY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; LIGAND BINDING; MAMMAL CELL; METHYLATION; NERVE CELL; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL;

ACONITINE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; CARBACHOL; CELLS, CULTURED; HUMANS; N-METHYLSCOPOLAMINE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PARASYMPATHOLYTICS; PYRIDINES; RATS; RECEPTORS, NICOTINIC; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; TRITIUM;

EID: 0141457718     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.4.865     Document Type: Article

References (38)

1. 3H]Methylcarbamylcholine, a new radioligand for studying brain nicotinic receptors. Biochem Pharmacol 35:4199-4202.
2. 3H]methylcarbamylcholine in rat brain. Eur J Pharmacol 253:261-267.
3. Arneric SP and Brioni JD eds (1999) Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities Wiley-Liss, Inc., New York, NY.
4. Avalos M, Parker MJ, Maddox FN, Carroll FI, and Luetje CW (2002) Effects of pyridine ring substitutions on affinity, efficacy and subtype selectivity of neuronal nicotinic receptor agonist epibatidine. J Pharmacol Exp Ther 302:1246-1252.
5. 3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine. Biochemistry 41:10262-10269.
6. Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smit AB, and Sixma TK (2001) Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature (Lond) 411:269-276.
7. Chahine M, Bennett PB, George AL Jr, and Horn R (1994) Functional expression and properties of the human skeletal muscle sodium channel. Pflügers Arch 427:136-142.
8. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, and Johnson EC (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346-356.
9. Cohen BN, Figl A, Quick MW, Labarca C, Davidson N, and Lester HA (1995) Regions of β2 and β4 responsible for differences between the steady state dose-response relationships of the α3β2 and α3β4 neuronal nicotinic receptors. J Gen Physiol 105:745-764.
10. Corringer P-J, Le Novère N, and Changeux J-P (2000) Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol 40:431-458.
11. Covernton PJ, Kojima H, Sivilotti LG, Gibb AJ, and Colquhoun D (1994) Comparison of neuronal nicotinic receptors in rat sympathetic neurones with subunit pairs expressed in Xenopus oocytes. J Physiol 481:27-34.
12. 3H] methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology 38:679-690.
13. Dineley KT and Patrick JW (2000) Amino acid determinants of α7 nicotinic acetylcholine receptor surface expression. J Biol Chem 275:13974-13985.
14. Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, and Brann MR (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256:727-733.
15. Dwoskin LP and Crooks PA (2001) Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery. J Pharmacol Exp Ther 298:395-402.
16. Eglen RM, Choppin A, and Watson N (2001) Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol Sci 22:409-414.
17. Eiselé J-L, Bertrand S, Galzi J-L, Devillers-Thiéry A, Changeux J-P, and Bertrand D (1993) Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities. Nature (Lond) 366:479-483.
18. Fitch RW, Xiao Y, Kellar KJ, and Daly JW (2003) Membrane potential fluorescence: a rapid and highly sensitive assay for nicotinic receptor channel function. Proc Natl Acad Sci USA 100:4909-4914.
19. Gotti C, Fornasari D, and Clementi F (1997) Human neuronal nicotinic receptors. Prog Brain Res 53:199-237.
20. Holladay MW, Dart MJ, and Lynch JK (1997) Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J Med Chem 40:4169-4194.
21. Karlin A (2002) Emerging structure of the nicotinic acetylcholine receptors. Nature (Lond) Rev Neurosci 3:102-114.
22. 2+-binding sites. Proc Natl Acad Sci USA 99:3210-3215.
23. Levin ED ed (2002) Nicotinic receptors in the nervous system. CRC Press, Boca Raton - London - New York - Washington, D. C.
24. 3H]Methyllycaconitine: a high affinity radioligand that labels invertebrate nicotinic acetylcholine receptors. Insect Biochem Mol Biol 31:533-542.
25. Lindstrom J (1997) Nicotinic acetylcholine receptors in health and disease. Mol Neurobiol 152:193-222.
26. Mukhin AG, Gundisch D, Horti AG, Koren AO, Tamagnan G, Kimes AS, Chambers J, Vaupel DB, King SL, Picciotto MR, Innis RB, and London ED (2000) 5-Iodo-A-85380, an α4β2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol 57:642-649.
27. Parker JC, Sarkar D, Quick MW, and Lester RA (2003) Interactions of atropine with heterologously expressed and native alpha3 subunit-containing nicotinic acetylcholine receptors. Br J Pharmacol 138:801-810.
28. Parker MJ, Beck A, and Luetje CW (1998) Neuronal nicotinic receptor β2 and β4 subunits confer large differences in agonist binding affinity. Mol Pharmacol 54: 1132-1139.
29. Punzi JS, Banerjee S, and Abood LG (1991) Structure-activity relationships for various N-alkylcarbamyl esters of choline with selective nicotinic cholinergic properties. Biochem Pharmacol 41:465-467.
30. 3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine and polyamines. J Neurochem 51:830-836.
31. Romanelli MN and Gualtieri F (2003) Cholinergic nicotinic receptors: competitive ligands, allosteric modulators and their potential applications. Med Res Rev 23: 393-426.
32. Sabey K, Paradiso K, Zhang J, and Steinbach JH (1999) Ligand binding and activation of rat nicotinic α4β2 receptors stably expressed in HEK293 cells. Mol Pharmacol 55:58-66.
33. Slater YE, Houlihan LM, Maskell PD, Exley R, Bermudez I, Lukas RJ, Valdivia AC, and Cassels BK (2003) Halogenated cytisine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes. Neuropharmacology 44:513-523.
34. Søkilde B, Mikkelsen I, Stensbøl TB, Andersen B, Ebdrup S, Krogsgaard-Larsen P, and Falch E (1996) Analogues of carbacholine: synthesis and relationship between structure and affinity for muscarinic and nicotinic acetylcholine receptors. Arch Pharm Pharm Med Chem 329:95-104.
35. Stauderman KA, Mahafy LS, Akong M, Velicelebi G, Chavez-Noriega LE, Crona JH, Johnson EC, Elliott KJ, Gillespie A, Reid RT, Adams P, Harpold MM and Corey-Naeve J (1998) Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations α2β4, α3β4 and stably expressed in HEK293 cells. J Pharmacol Exp Ther 284:777-789.
36. Xiao Y, Meyer EL, Thompson JM, Surin A, Wroblewski J, and Kellar KJ (1998) Rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function. Mol Pharmacol 54:322-333.
37. Zacharias N and Dougherty DA (2002) Cation-π interactions in ligand recognition and catalysis. Trends Pharmacol Sci 23:281-287.
38. Zhong W, Gallivan JP, Zhang Y, Li L, Lester HA, and Dougherty DA (1998) From ab initio quantum mechanics to molecular neurobiology: a cation-π binding site in the nicotinic receptor. Proc Natl Acad Sci USA 95:12088-12093.